The Canadian Bioceutical Corporation Announces Name Change to MPX Bioceutical Corporation Election of Board of DirectorsAppoint Deloitte LLP as AuditorAppointment of OfficersIssuance of Stock OptionsEntering into Executive Services Agreement with Canadian Capital, LLC TORONTO, Nov. 02,...

BCC to Enter Into Joint Venture With Israeli Pharmaceutical Company Panaxia Differentiation into high-growth market segment under new “Salus Bio-Pharma” brand JV will launch in Arizona & Massachusetts and, post closing of the acquisitions, in Nevada and Maryland. ...

BCC Successfully Relocates Dispensary With First Week Sales Record TORONTO, May 31, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTCQB:CBICF) today announced that one of the two Health for Life dispensaries...

BCC Commences Trading on OTCQB TORONTO, May 22, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTCQB:CBICF) announced that BCC common shares will commence trading in the...